hydroxyurea has been researched along with Constriction, Pathological in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with hydroxyurea and CTT were obtained from the chart review." | 1.72 | Evolution of Extracranial Internal Carotid Artery Disease in Children With Sickle Cell Anemia. ( Alison, M; Balandra, S; Belarbi, N; Bernaudin, F; Cussenot, I; Elmaleh, M; Ithier, G; Kheniche, A; Ntorkou, A; Oloukoi, C; Ouaziz, H; Sekkal, A; Tanase, A; Verlhac, S, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Verlhac, S | 1 |
| Ithier, G | 1 |
| Bernaudin, F | 1 |
| Oloukoi, C | 1 |
| Cussenot, I | 1 |
| Balandra, S | 1 |
| Kheniche, A | 1 |
| Ntorkou, A | 1 |
| Ouaziz, H | 1 |
| Tanase, A | 1 |
| Sekkal, A | 1 |
| Belarbi, N | 1 |
| Elmaleh, M | 1 |
| Alison, M | 1 |
| Grace, RF | 1 |
| Su, H | 1 |
| Sena, L | 1 |
| Poussaint, TY | 1 |
| Heeney, MM | 1 |
| Gutierrez, A | 1 |
| Amrolia, PJ | 1 |
| Almeida, A | 1 |
| Davies, SC | 1 |
| Roberts, IA | 1 |
| Schnog, JB | 1 |
| Duits, AJ | 1 |
| Muskiet, FA | 1 |
| ten Cate, H | 1 |
| Rojer, RA | 1 |
| Brandjes, DP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| PINPOINT: Gaming Technology to Engage Adolescent Sickle Cell Patients in Precision Pain Management[NCT03291613] | 13 participants (Actual) | Interventional | 2017-01-15 | Completed | |||
| Interest of Nutritional Care of Children With Sickle Cell Disease on Bone Mineral Density and Body Composition[NCT04754711] | 70 participants (Anticipated) | Interventional | 2021-09-23 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
"Ten likert-type questions assessing user-friendliness of technology. Each question has five answer options that range from Strongly Agree to Strongly Disagree. Scores range from 0-100. A score of 68 or above is considered above average. All scores averaged." (NCT03291613)
Timeframe: After 1-hour usability session
| Intervention | units on a scale (Mean) |
|---|---|
| Pinpoint App | 86.67 |
2 reviews available for hydroxyurea and Constriction, Pathological
| Article | Year |
|---|---|
Therapeutic challenges in childhood sickle cell disease. Part 2: a problem-orientated approach.
Topics: Anemia, Sickle Cell; Antisickling Agents; Bone Marrow Transplantation; Central Nervous System Diseas | 2003 |
Sickle cell disease; a general overview.
Topics: Anemia, Sickle Cell; Blood Transfusion; Constriction, Pathologic; Hemoglobin, Sickle; Hemolysis; Hum | 2004 |
Sickle cell disease; a general overview.
Topics: Anemia, Sickle Cell; Blood Transfusion; Constriction, Pathologic; Hemoglobin, Sickle; Hemolysis; Hum | 2004 |
Sickle cell disease; a general overview.
Topics: Anemia, Sickle Cell; Blood Transfusion; Constriction, Pathologic; Hemoglobin, Sickle; Hemolysis; Hum | 2004 |
Sickle cell disease; a general overview.
Topics: Anemia, Sickle Cell; Blood Transfusion; Constriction, Pathologic; Hemoglobin, Sickle; Hemolysis; Hum | 2004 |
2 other studies available for hydroxyurea and Constriction, Pathological
| Article | Year |
|---|---|
Evolution of Extracranial Internal Carotid Artery Disease in Children With Sickle Cell Anemia.
Topics: Anemia, Sickle Cell; Carotid Artery Diseases; Carotid Artery, Internal; Carotid Stenosis; Cerebral I | 2022 |
Resolution of cerebral artery stenosis in a child with sickle cell anemia treated with hydroxyurea.
Topics: Anemia, Sickle Cell; Antisickling Agents; Blood Flow Velocity; Cerebral Arterial Diseases; Cerebral | 2010 |